Your browser doesn't support javascript.
loading
Strategies to improve healthcare services for patients with sickle cell disease in Nigeria: The perspectives of stakeholders.
Isa, Hezekiah; Okocha, Emmanuel; Adegoke, Samuel Ademola; Nnebe-Agumadu, Uche; Kuliya-Gwarzo, Aisha; Sopekan, Alayo; Ofakunrin, Akinyemi Olugbenga; Ugwu, Ngozi; Hassan, Abdul-Aziz; Ohiaeri, Chinatu; Madu, Anazoeze; Diaku-Akinwumi, Ijeoma; Ekwem, Lilian; Dogara, Livingstone Gayus; Okoh, Dorothy; Jasini, James; Girei, Ahmed; Ekwere, Timothy; Okolo, Angela; Kangiwa, Umar; Lawson, Juliet; Chianumba, Reuben; Brown, Biobele; Akinola, Norah; Nwegbu, Maxwell; Nnodu, Obiageli.
Afiliación
  • Isa H; Centre of Excellence for Sickle Cell Research and Training, University of Abuja (CESRTA) Federal Capital Territory (FCT), Abuja, Nigeria.
  • Okocha E; Department of Haematology and Blood Transfusion, University of Abuja, Abuja, Nigeria.
  • Adegoke SA; Department of Haematology, Nnamdi Azikiwe University Teaching Hospital Nnewi, Nnewi, Anambara State, Nigeria.
  • Nnebe-Agumadu U; Department of Paediatrics and Child health, Obafemi Awolowo University, Ile Ife, Osun State, Nigeria.
  • Kuliya-Gwarzo A; Department of Paediatrics, University of Abuja Teaching Hospital, Abuja, Nigeria.
  • Sopekan A; Department of Haematology, Aminu Kano University Teaching Hospital, Kano, Kano State, Nigeria.
  • Ofakunrin AO; Non Communicable Disease Unit, Federal Ministry of Health, Federal Secretariat, Abuja, Nigeria.
  • Ugwu N; Department of Paediatrics, Jos University Teaching Hospital, Jos, Nigeria.
  • Hassan AA; Department of Haematology, Alex Ekweme Federal Teaching Hospital, Abakaliki, Ebonyi State, Nigeria.
  • Ohiaeri C; Department of Haematology and Blood Transfusion, Ahmadu Bello University, Zaria, Kaduna State, Nigeria.
  • Madu A; Department of Paediatrics, Federal Medical Centre Keffi, Keffi, Nasarawa State, Nigeria.
  • Diaku-Akinwumi I; Department of Haematology, University of Nigeria Teaching Hospital, Enugu, Enugu State, Nigeria.
  • Ekwem L; Department of Paediatrics, Lagos State University Teaching Hospital, Ikeja, Lagos State, Nigeria.
  • Dogara LG; Department of Paediatrics, General Hospital Nyanya, Abuja, Nigeria.
  • Okoh D; Departments of Haematology and Blood Transfusion, Kaduna State University Teaching Hospital, Kaduna, Kaduna State, Nigeria.
  • Jasini J; Department of Haematology, Rivers State University, Port Harcourt, Rivers State, Nigeria.
  • Girei A; Department of Haematology, Federal Medical Centre, Yola, Adamawa State, Nigeria.
  • Ekwere T; Department of Haematology, Federal Teaching Hospital Gombe, Gombe, Gombe State, Nigeria.
  • Okolo A; Department of Haematology, University of Uyo, Uyo, Akwa IbomState, Nigeria.
  • Kangiwa U; Federal Medical Centre Asaba, Asaba, Delta State, Nigeria.
  • Lawson J; Department of Haematology, Federal Medical Centre, Birnin Kebbi, Kebbi State, Nigeria.
  • Chianumba R; Department of Paediatrics, Zankli Medical Centre, Abuja, Nigeria.
  • Brown B; Centre of Excellence for Sickle Cell Research and Training, University of Abuja (CESRTA) Federal Capital Territory (FCT), Abuja, Nigeria.
  • Akinola N; Department of Paediatrics, University College Hospital, Ibadan, Oyo State, Nigeria.
  • Nwegbu M; Department of Haematology, Obafemi Awolowo University Teaching Hospital, Ile Ife, Osun State, Nigeria.
  • Nnodu O; Centre of Excellence for Sickle Cell Research and Training, University of Abuja (CESRTA) Federal Capital Territory (FCT), Abuja, Nigeria.
Front Genet ; 14: 1052444, 2023.
Article en En | MEDLINE | ID: mdl-36816043
ABSTRACT

Background:

Sickle cell disease (SCD) continues to pose physical and psychosocial burdens to patients, caregivers and health workers. Stakeholder engagement in the processes of policy making and implementation is increasingly becoming the cornerstone of best practices in healthcare. Aim and

Objectives:

To engage stakeholders with a view to assessing the knowledge of SCD; ascertain the challenges associated with accessibility and affordability of healthcare services; improve the quality of care, and thereby effect behavioral change through increasing attendance and follow-up of patients in the clinics.

Methodology:

A Stakeholders' Engagement meeting organized by the Sickle Pan Africa Research Consortium Nigeria Network (SPARC-NEt) was attended by patients, caregivers and members of patient support groups, healthcare providers and management/policymakers. The engagement was through PowerPoint presentations, structured questionnaires and an interactive session. The structured questionnaire assessed the knowledge of stakeholders about SCD; the quality of healthcare services; challenges with access and affordability; and SCD-related government policies.

Results:

Three hundred and twelve stakeholders attended the engagement meeting. Of the 133 that participated in the study, medical workers were the most represented. The majority had good knowledge of what causes SCD (96.2%) and the best place to get help during SCD crisis (98.5%). However, knowledge of the specific preventive measures of SCD and its crisis was not optimal. In terms of the role of community engagement and education, only about one-quarter of the study participants, 34 (25.6%) knew about their positive role in reducing the prevalence of SCD and alleviating SCD crises. Challenges identified include inadequate healthcare personnel and facilities, delay in obtaining laboratory results, long waiting time in the clinic, poor communication, absence of holistic consultation, uncoordinated healthcare services, high cost of care, ignorance, non-prioritization of SCD by government, lack of multisectoral collaboration and partnership with NGOs and international organizations. Strategies proffered to improve healthcare services include, community/stakeholder engagement and health education, sickle cell daycare services, access to a willing and dedicated multidisciplinary workforce, collaboration with support groups and government policies and programs.

Conclusion:

There is need for regular stakeholder engagement to improve access to healthcare services for SCD patients in Nigeria.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Qualitative_research / Risk_factors_studies Idioma: En Revista: Front Genet Año: 2023 Tipo del documento: Article País de afiliación: Nigeria

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Qualitative_research / Risk_factors_studies Idioma: En Revista: Front Genet Año: 2023 Tipo del documento: Article País de afiliación: Nigeria
...